Latest News

COVID vaccines could lose their punch within a year, experts say


 

“Dire, but not surprising”

Panagis Galiatsatos, MD, MHS, a pulmonologist at John Hopkins University, Baltimore, whose research focuses on health care disparities, said the survey findings were “dire, but not surprising.”

Johns Hopkins was another of the centers surveyed, but Dr. Galiatsatos wasn’t personally involved with the survey.

COVID-19, Dr. Galiatsatos pointed out, has laid bare disparities, both in who gets the vaccine and who’s involved in trials to develop the vaccines.

“It’s morally concerning and an ethical reckoning,” he said in an interview.

Recognition of the borderless swath of destruction the virus is exacting is critical, he said.

The United States “has to realize this can’t be a U.S.-centric issue,” he said. “We’re going to be back to the beginning if we don’t make sure that every country is doing well. We haven’t seen that level of uniform approach.”

He noted that scientists have always known that viruses mutate, but now the race is on to find the parts of SARS-CoV-2 that don’t mutate as much.

“My suspicion is we’ll probably need boosters instead of a whole different vaccine,” Dr. Galiatsatos said.

Among the strategies sought by the People’s Vaccine Alliance is for all pharmaceutical companies working on COVID-19 vaccines to openly share technology and intellectual property through the World Health Organization COVID-19 Technology Access Pool, to speed production and rollout of vaccines to all countries.

In the survey, 74% said that open sharing of technology and intellectual property could boost global vaccine coverage; 23% said maybe and 3% said it wouldn’t help.

The survey was carried out between Feb. 17 and March 25, 2021. Respondents included epidemiologists, virologists, and infection disease specialists from the following countries: Algeria, Argentina, Australia, Belgium, Bolivia, Canada, Denmark, Ethiopia, France, Guatemala, India, Italy, Kenya, Lebanon, Norway, Philippines, Senegal, Somalia, South Africa, South Sudan, Spain, United Arab Emirates, Uganda, United Kingdom, United States, Vietnam, Zambia, and Zimbabwe.

Dr. Offit and Dr. Galiatsatos reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Fauci worries about possible post–COVID-19 ‘mental health pandemic’
MDedge Emergency Medicine
We’re all vaccinated: Can we go back to the office (unmasked) now?
MDedge Emergency Medicine
COVID-19 virus reinfections rare; riskiest after age 65
MDedge Emergency Medicine
High obesity rates in Southern states magnify COVID threats
MDedge Emergency Medicine
Update: U.S. regulators question AstraZeneca vaccine trial data
MDedge Emergency Medicine
COVID-19 can cause atypical thyroid inflammation
MDedge Emergency Medicine
Encephalopathy common, often lethal in hospitalized patients with COVID-19
MDedge Emergency Medicine
COVID-19 ‘long-haul’ symptoms overlap with ME/CFS
MDedge Emergency Medicine
Long-haul COVID-19 brings welcome attention to POTS
MDedge Emergency Medicine
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
MDedge Emergency Medicine